Inhibition of Aortic Valve Calcification by Local Delivery of Zoledronic Acid—an Experimental Study-Reference-Cited by-同舟云学术

Inhibition of Aortic Valve Calcification by Local Delivery of Zoledronic Acid—an Experimental Study

Published:2018-03-26 Issue:3 Volume:11 Page:192-200
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Synetos Andreas^ORCID,Toutouzas Konstantinos,Drakopoulou Maria,Koutagiar Iosif,Benetos George,Kotronias Rafail,Anousakis-Vlachochristou Nikolaos,Latsios George,Karanasos Antonis,Agrogiannis George,Metaxas Marinos,Stathogiannis Konstantinos,Papanikolaou Aggelos,Georgakopoulos Alexandros,Pianou Nikoleta,Tsiamis Eleftherios,Patsouris Efstratios,Papalois Apostolos,Cokkinos Dennis,Anagnostopoulos Constantinos,Tousoulis Dimitrios

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s12265-018-9802-4/fulltext.html

Reference36 articles.

1. Synetos, A., Toutouzas, K., Benetos, G., Drakopoulou, M., Trantalis, G., Kotronias, R., et al. (2014). Catheter based inhibition of arterial calcification by bisphosphonates in an experimental atherosclerotic rabbit animal model. International Journal of Cardiology, 176(1), 177–181. https://doi.org/10.1016/j.ijcard.2014.07.008 .

2. Dweck, M. R., Jenkins, W. S., Vesey, A. T., Pringle, M. A., Chin, C. W., Malley, T. S., et al. (2014). 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circulation. Cardiovascular Imaging, 7(2), 371–378. https://doi.org/10.1161/CIRCIMAGING.113.001508 .

3. Dweck, M. R., Chow, M. W., Joshi, N. V., Williams, M. C., Jones, C., Fletcher, A. M., et al. (2012). Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. Journal of the American College of Cardiology, 59(17), 1539–1548. https://doi.org/10.1016/j.jacc.2011.12.037 .

4. Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., et al. (1997). Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. Journal of the American College of Cardiology, 29(3), 630–634.

5. Mohler, E. R., Sheridan, M. J., Nichols, R., Harvey, W. P., & Waller, B. F. (1991). Development and progression of aortic valve stenosis: atherosclerosis risk factors—a causal relationship? A clinical morphologic study. Clinical Cardiology, 14(12), 995–999.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitrogen-containing bisphosphonate for vascular calcification: animal experiments and a meta-analysis;2024-03-04

2. Animal Model of Aortic Valve Calcification: Their Methodology Helps Us Understand Aortic Valve Calcification;Advances in Bioscience and Biotechnology;2024

3. Severe early-onset manifestations of generalized arterial calcification of infancy (mimicking severe coarctation of the aorta) with ABCC6 gene variant — Case report and literature review;Frontiers in Cardiovascular Medicine;2022-12-20

4. Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review);Sovremennye tehnologii v medicine;2022-04-28

5. Impact of osteogenic activity on degenerative aortic valve disease in patients with osteoporotic hip fracture;Journal of Cardiology;2021-11